回应再探讨：“基层医疗机构中多民族门诊老年 2 型糖尿病患者肌少症的流行情况及相关因素”。
Response to Revisiting: "Prevalence of and factors associated with sarcopenia among multi-ethnic ambulatory older Asians with type 2 diabetes mellitus in a primary care setting".
机构信息
MOH Holdings, 1 Maritime Square, #11-25 HarbourFront Centre, Singapore, 099253, Singapore.
SingHealth Polyclinics, SingHealth-Duke NUS Family Medicine Academic Clinical Programme, 167 Jalan Bukit Merah, Connection One, Tower 5, #15-10, Singapore, 150167, Singapore.
出版信息
BMC Geriatr. 2021 Dec 11;21(1):690. doi: 10.1186/s12877-021-02563-6.
Abstract
To address and clarify the concerns of fellow researchers of "Revisiting: "Prevalence of and factors associated with sarcopenia among multi-ethnic ambulatory older Asians with type 2 diabetes mellitus in a primary care setting". While chronic obstructive pulmonary disease may be a contributing factor, it is our study limitation to capture a significant number of patients with chronic obstructive pulmonary disease for analyses. Also, ethnicity is not associated with sarcopenia.
摘要
为了解决并澄清“重新审视：在初级保健环境中多民族门诊老年 2 型糖尿病亚洲人中与肌少症相关的患病率和因素”的研究人员的担忧。虽然慢性阻塞性肺疾病可能是一个促成因素，但我们的研究限制是无法为分析捕获到大量患有慢性阻塞性肺疾病的患者。此外，种族与肌少症无关。
相似文献
1
Response to Revisiting: "Prevalence of and factors associated with sarcopenia among multi-ethnic ambulatory older Asians with type 2 diabetes mellitus in a primary care setting".回应再探讨：“基层医疗机构中多民族门诊老年 2 型糖尿病患者肌少症的流行情况及相关因素”。
BMC Geriatr. 2021 Dec 11;21(1):690. doi: 10.1186/s12877-021-02563-6.
2
Prevalence of and factors associated with sarcopenia among multi-ethnic ambulatory older Asians with type 2 diabetes mellitus in a primary care setting.在基层医疗环境中，患有 2 型糖尿病的多民族门诊老年亚洲人中，与肌肉减少症相关的流行率及因素。
BMC Geriatr. 2019 Apr 29;19(1):122. doi: 10.1186/s12877-019-1137-8.
3
Revisiting: "prevalence of and factors associated with sarcopenia among multi-ethnic ambulatory older Asians with type 2 diabetes mellitus in a primary care setting".重温：“基层医疗环境中多民族非卧床2型糖尿病老年亚洲人肌肉减少症的患病率及相关因素”
BMC Geriatr. 2020 Oct 20;20(1):415. doi: 10.1186/s12877-020-01727-0.
4
Longitudinal study on the progression of muscle status among community-dwelling ambulatory older multiethnic Asians with type 2 diabetes mellitus.社区居住、行动自如的多民族 2 型糖尿病老年亚洲人中肌肉状况进展的纵向研究。
BMC Geriatr. 2022 May 21;22(1):446. doi: 10.1186/s12877-022-03098-0.
5
Prevalence and Associations of Obstructive Sleep Apnea in South Asians and White Europeans with Type 2 Diabetes: A Cross-Sectional Study.南亚和欧洲白种2型糖尿病患者阻塞性睡眠呼吸暂停的患病率及相关性：一项横断面研究
J Clin Sleep Med. 2017 Apr 15;13(4):583-589. doi: 10.5664/jcsm.6548.
6
Diagnostic differences and agreement between the original and revised European Working Group (EWGSOP) consensus definition for sarcopenia in community-dwelling older adults with type 2 diabetes mellitus.社区居住的 2 型糖尿病老年人群中肌少症的原始和修订的欧洲工作组（EWGSOP）共识定义之间的诊断差异和一致性。
Arch Gerontol Geriatr. 2020 Jul-Aug;89:104081. doi: 10.1016/j.archger.2020.104081. Epub 2020 Apr 21.
7
The prevalence of sarcopenic obesity and its association with cognitive performance in type 2 diabetes in Singapore.新加坡 2 型糖尿病患者中肌少症性肥胖的流行及其与认知表现的关系。
Clin Nutr. 2020 Jul;39(7):2274-2281. doi: 10.1016/j.clnu.2019.10.019. Epub 2019 Nov 4.
8
Associations between homocysteine, inflammatory cytokines and sarcopenia in Chinese older adults with type 2 diabetes.中国 2 型糖尿病老年患者同型半胱氨酸、炎性细胞因子与肌肉减少症的相关性研究。
BMC Geriatr. 2021 Dec 15;21(1):692. doi: 10.1186/s12877-021-02622-y.
9
Risk Assessment of Sarcopenia in Patients With Type 2 Diabetes Mellitus Using Data Mining Methods.基于数据挖掘方法评估 2 型糖尿病患者的肌肉减少症风险。
Front Endocrinol (Lausanne). 2020 Mar 10;11:123. doi: 10.3389/fendo.2020.00123. eCollection 2020.
10
Sarcopenia Is Highly Prevalent in Older Medical Patients With Mobility Limitation.患有活动能力受限的老年住院患者中肌少症的患病率非常高。
Nutr Clin Pract. 2017 Feb;32(1):110-115. doi: 10.1177/0884533616680355. Epub 2016 Nov 24.
本文引用的文献
1
The prevalence and factors associated with sarcopenia among community living elderly with type 2 diabetes mellitus in primary care clinics in Malaysia.马来西亚基层医疗诊所中 2 型糖尿病社区老年患者肌少症的患病率及相关因素。
PLoS One. 2020 May 20;15(5):e0233299. doi: 10.1371/journal.pone.0233299. eCollection 2020.
2
Sarcopenia in COPD: a systematic review and meta-analysis.COPD 中的肌肉减少症：系统评价和荟萃分析。
Eur Respir Rev. 2019 Nov 13;28(154). doi: 10.1183/16000617.0049-2019. Print 2019 Dec 31.
3
Prevalence of and factors associated with sarcopenia among multi-ethnic ambulatory older Asians with type 2 diabetes mellitus in a primary care setting.在基层医疗环境中，患有 2 型糖尿病的多民族门诊老年亚洲人中，与肌肉减少症相关的流行率及因素。
BMC Geriatr. 2019 Apr 29;19(1):122. doi: 10.1186/s12877-019-1137-8.
4
Sarcopenia correlates with systemic inflammation in COPD.肌肉减少症与慢性阻塞性肺疾病中的全身炎症相关。
Int J Chron Obstruct Pulmon Dis. 2017 Feb 20;12:669-675. doi: 10.2147/COPD.S130790. eCollection 2017.
5
Sarcopenia and frailty in chronic respiratory disease.慢性呼吸道疾病中的肌肉减少症和衰弱症
Chron Respir Dis. 2017 Feb;14(1):85-99. doi: 10.1177/1479972316679664. Epub 2017 Feb 24.
6
Sarcopenia: burden and challenges for public health.肌肉减少症：公共健康的负担和挑战。
Arch Public Health. 2014 Dec 18;72(1):45. doi: 10.1186/2049-3258-72-45. eCollection 2014.
7
Quality of life in sarcopenia and frailty.肌少症和衰弱症患者的生活质量。
Calcif Tissue Int. 2013 Aug;93(2):101-20. doi: 10.1007/s00223-013-9758-y. Epub 2013 Jul 5.
8
Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People.肌肉减少症：欧洲定义和诊断共识：老年人肌肉减少症欧洲工作组报告。
Age Ageing. 2010 Jul;39(4):412-23. doi: 10.1093/ageing/afq034. Epub 2010 Apr 13.
9
Co-morbid association of depression and COPD: a population-based study.抑郁与 COPD 的共病关联：一项基于人群的研究。
Respir Med. 2009 Jun;103(6):895-901. doi: 10.1016/j.rmed.2008.12.010. Epub 2009 Jan 10.
10
The healthcare costs of sarcopenia in the United States.美国肌肉减少症的医疗保健成本。
J Am Geriatr Soc. 2004 Jan;52(1):80-5. doi: 10.1111/j.1532-5415.2004.52014.x.
Zotero 插件